2024 Journal Article Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific StatementKaravitaki, Niki, Bettinger, Jeffrey J., Biermasz, Nienke, Christ-Crain, Mirjam, Gadelha, Monica R., Inder, Warrick J., Tsourdi, Elena, Wakeman, Sarah E. and Zatelli, Maria (2024). Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement. Endocrine Reviews, 45 (6), 773-794. doi: 10.1210/endrev/bnae023 |
2024 Conference Publication Two Years Of Testosterone Therapy Reduces Glycemia In Males At High Risk Of Type 2 Diabetes Without Affecting Beta Cell Function: Results From A Randomised Controlled Trial And Cellular ModelUmapathysivam, M., Nawaz, S., Robledo, K., Allan, C. A., Bracken, K., Grossmann, M., Handelsman, D. J., Inder, W. J., Jesudason, D., Stuckey, B., Yeap, B., Januszewski, A., Jenkins, A., Conway, A., Hastoy, B. and Wittert, G. A. (2024). Two Years Of Testosterone Therapy Reduces Glycemia In Males At High Risk Of Type 2 Diabetes Without Affecting Beta Cell Function: Results From A Randomised Controlled Trial And Cellular Model. ENDO 2024 Annual Meeting of the Endocrine Society, Boston, MA United States, 1-4 June 2024. Cary, NC United States: Oxford University Press. doi: 10.1210/jendso/bvae163.981 |
2024 Journal Article Testosterone treatment, weight loss and health-related quality of life and psychosocial function in men: a two-year RCTGrossmann, Mathis, Robledo, Kristy P., Daniel, Mark, Handelsman, David J., Inder, Warrick J., Stuckey, Bronwyn G. A., Yeap, Bu B., Ng Tang Fui, Mark, Bracken, Karen, Allan, Carolyn A., Jesudason, David, Zajac, Jeffrey D. and Wittert, Gary A. (2024). Testosterone treatment, weight loss and health-related quality of life and psychosocial function in men: a two-year RCT. The Journal of Clinical Endocrinology and Metabolism, 109 (8), 2019-2028. doi: 10.1210/clinem/dgae085 |
2024 Journal Article Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2Lenders, Nèle F., Thompson, Tanya J., Chui, Jeanie, Low, Julia, Inder, Warrick J., Earls, Peter E. and McCormack, Ann I. (2024). Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2. Pituitary, 27 (3), 248-258. doi: 10.1007/s11102-024-01385-0 |
2024 Journal Article The glucocorticoid receptor: isoforms, functions, and contribution to glucocorticoid sensitivityLockett, Jack, Inder, Warrick J and Clifton, Vicki L (2024). The glucocorticoid receptor: isoforms, functions, and contribution to glucocorticoid sensitivity. Endocrine Reviews, 45 (4), 593-624. doi: 10.1210/endrev/bnae008 |
2024 Journal Article Long-term outcomes of testosterone treatment in men: A T4DM post-randomisation observational follow-up studyHandelsman, David J., Grossmann, Mathis, Yeap, Bu B., Stuckey, Bronwyn G. A., Shankara-Narayana, Nandini, Conway, Ann J., Inder, Warrick J., McLachlan, Robert I., Allan, Carolyn, Jenkins, Alicia J., Jesudason, David, Bracken, Karen and Wittert, Gary A. (2024). Long-term outcomes of testosterone treatment in men: A T4DM post-randomisation observational follow-up study. The Journal of Clinical Endocrinology and Metabolism, 109 (1), e25-e31. doi: 10.1210/clinem/dgad485 |
2023 Conference Publication Long-term Self-reported Outcomes Of Randomized Testosterone (T) vs Placebo (P) Treatment In The T4DM StudyHandelsman, David J., Grossmann, Mathis, Yeap, Bu Beng, Stuckey, Bronwyn G. A., Shankara-Narayana, Nandini, Conway, Ann J., Inder, Warrick, McLachlan, Robert I., Allan, Carolyn A., Jenkins, Alicia, Jesudason, David R., Bracken, Karen, Robledo, Kristy and Wittert, Gary A. (2023). Long-term Self-reported Outcomes Of Randomized Testosterone (T) vs Placebo (P) Treatment In The T4DM Study. Annual Meeting of the Endocrine Society ENDO 2023, Chicago, IL United States, 15-18 June 2023. Cary, NC United States: Oxford University Press. doi: 10.1210/jendso/bvad114.1625 |
2023 Conference Publication Testosterone Treatment And Sexual Function In Men With Or At Risk Of T2D: The T4DM StudyWittert, Gary Allen, Robledo, Kristy, Grossmann, Mathis, Yeap, Bu Beng, Ann Stuckey, Bronwyn Gwenneth, Inder, Warrick John, Bracken, Karen, Jesudason, David R., Allan, Carolyn A. and Handelsman, David J. (2023). Testosterone Treatment And Sexual Function In Men With Or At Risk Of T2D: The T4DM Study. Annual Meeting of the Endocrine Society ENDO 2023, Chicago, IL United States, 15-18 June 2023. Cary, NC United States: Oxford University Press. doi: 10.1210/jendso/bvad114.1555 |
2023 Journal Article Elevated insulin‐like growth factor‐1 in patients without clinical evidence of acromegalyCareless, Laura, Inder, Warrick J., Pretorius, Carel and Hayes, Lisa (2023). Elevated insulin‐like growth factor‐1 in patients without clinical evidence of acromegaly. Clinical Endocrinology, 99 (3), 296-305. doi: 10.1111/cen.14917 |
2023 Journal Article Obesity and ‘functional hypogonadism’ – mechanisms and management: Commentary on EJE-22-1110 “Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT”Inder, Warrick J and Grossmann, Mathis (2023). Obesity and ‘functional hypogonadism’ – mechanisms and management: Commentary on EJE-22-1110 “Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT”. European Journal of Endocrinology, 189 (3), R7-R9. doi: 10.1093/ejendo/lvad100 |
2023 Journal Article Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trialRobledo, Kristy P., Marschner, Ian C., Handelsman, David J., Bracken, Karen, Stuckey, Bronwyn G A, Yeap, Bu B., Inder, Warrick, Grossmann, Mathis, Jesudason, David, Allan, Carolyn A. and Wittert, Gary (2023). Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial. European Journal of Endocrinology, 188 (7), 613-620. doi: 10.1093/ejendo/lvad074 |
2023 Conference Publication A novel online learning activity to develop person-centred history taking and clinical reasoning skills in preclinical medical studentsReddy, Venkat, Greentree, Charley, Cain, Justine, Inder, Warrick and Stedman, Sharee (2023). A novel online learning activity to develop person-centred history taking and clinical reasoning skills in preclinical medical students. Australian and New Zealand Association of Health Professional Educators, Gold Coast, QLD Australia, 26-29 June 2023. |
2023 Journal Article The evolution in pituitary tumour classification: a clinical perspectiveLenders, Nele F., Earls, Peter E., Inder, Warrick J. and McCormack, Ann I. (2023). The evolution in pituitary tumour classification: a clinical perspective. Endocrine Oncology, 3 (1) e220079, 1-13. doi: 10.1530/eo-22-0079 |
2023 Journal Article Pituitary tumours: molecular and genetic aspectsDe Sousa, Sunita M. C., Lenders, Nele F., Lamb, Lydia, Inder, Warrick J. and McCormack, Ann I. (2023). Pituitary tumours: molecular and genetic aspects. Journal of Endocrinology, 257 (3) e220291, 1-16. doi: 10.1530/joe-22-0291 |
2023 Journal Article Approach to the patient – disorders of salt and water balance post pituitary surgeryBrooks, Emily K. and Inder, Warrick J. (2023). Approach to the patient – disorders of salt and water balance post pituitary surgery. The Journal of Clinical Endocrinology and Metabolism, 108 (1), 198-208. doi: 10.1210/clinem/dgac622 |
2022 Conference Publication Evaluation of elevated IGF-1 in patients without clinical evidence of acromegalyCareless, Laura, Inder, Warrick, Pretorius, Carel and Hayes, Lisa (2022). Evaluation of elevated IGF-1 in patients without clinical evidence of acromegaly. ENDO 2022, Atlanta, GA United States, 11-14 June 2022. Cary, NC United States: Oxford University Press. doi: 10.1210/jendso/bvac150.1160 |
2022 Journal Article Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumoursLenders, N. F., Chui, J., Low, J., Inder, W. J., Earls, P. E. and McCormack, A. I. (2022). Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours. Pituitary, 25 (6), 1-7. doi: 10.1007/s11102-022-01284-2 |
2022 Book Chapter Adrenal disease in pregnancyLockett, Jack, Inder, Warrick, McIntyre, David H., Barrett, Helen L., Kumar, Sailesh and Clifton, Vicki Lee (2022). Adrenal disease in pregnancy. Hormones and pregnancy. (pp. 164-182) edited by Felice Petraglia, Mariarosaria Di Tommaso and Federico Mecacci. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/9781009030830.015 |
2022 Journal Article Treatment of prolactinomaInder, Warrick J. and Jang, Christina (2022). Treatment of prolactinoma. Medicina (Kaunas, Lithuania), 58 (8) 1095, 1095. doi: 10.3390/medicina58081095 |
2022 Journal Article Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injectionsHandelsman, David J., Desai, Reena, Conway, Ann J., Shankara-Narayana, Nandini, Stuckey, Bronwyn G. A., Inder, Warrick J., Grossmann, Mathis, Yeap, Bu Beng, Jesudason, David, Ly, Lam P., Bracken, Karen and Wittert, Gary Allen (2022). Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections. European Journal of Endocrinology, 186 (3), 307-318. doi: 10.1530/EJE-21-0608 |